13.18BMarket Cap-77.70P/E (TTM)
18.603High17.710Low7.10MVolume18.020Open18.400Pre Close127.54MTurnover6.18%Turnover RatioLossP/E (Static)737.45MShares33.89052wk High30.08P/B2.05BFloat Cap2.10052wk Low--Dividend TTM114.94MShs Float33.890Historical High--Div YieldTTM4.85%Amplitude0.660Historical Low17.965Avg Price1Lot Size
Summit Therapeutics Stock Forum
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet